Comment on “Lung Transplantation for Elderly Patients With End-stage COVID-19 Pneumonia”

2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Ashley Baquero ◽  
David H. Beyda ◽  
Maria Fiatarone Singh ◽  
Glynn Gilcrease ◽  
Joseph E. Gutierrez ◽  
...  
2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Weili Han ◽  
Manhua Zhu ◽  
Jun Chen ◽  
Jing Zhang ◽  
Shengmei Zhu ◽  
...  

2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Weili Han ◽  
Manhua Zhu ◽  
Jun Chen ◽  
Tingbo Liang

2020 ◽  
Vol 272 (1) ◽  
pp. e33-e34 ◽  
Author(s):  
Weili Han ◽  
Manhua Zhu ◽  
Jun Chen ◽  
Jing Zhang ◽  
Shengmei Zhu ◽  
...  

2021 ◽  
Vol 30 (3) ◽  
pp. 178-183
Author(s):  
Kate McEwen ◽  
Lyndell Brodie

Lung transplantation is a well-established treatment for a variety of end-stage pulmonary diseases. However, the journey of a lung transplant recipient is complex and multifaceted. Silicosis is a rare indication for lung transplantation, but no other treatment is yet available for this disease in its end stages. This Australian case study presents a 52-year-old man with silicosis who received bilateral lung transplantation. The patient was frequently noncompliant with noninvasive ventilation therapy and experienced the complication of type 2 respiratory failure. Patient education and support provided, particularly around medication management following transplantation surgery, are discussed here. The patient's social situation and its implications for both him and his family are also considered.


F1000Research ◽  
2018 ◽  
Vol 7 ◽  
pp. 1684 ◽  
Author(s):  
Keith C Meyer

Lung transplantation can improve quality of life and prolong survival for individuals with end-stage lung disease, and many advances in the realms of both basic science and clinical research aspects of lung transplantation have emerged over the past few decades. However, many challenges must yet be overcome to increase post-transplant survival. These include successfully bridging patients to transplant, expanding the lung donor pool, inducing tolerance, and preventing a myriad of post-transplant complications that include primary graft dysfunction, forms of cellular and antibody-mediated rejection, chronic lung allograft dysfunction, and infections. The goal of this manuscript is to review salient recent and evolving advances in the field of lung transplantation.


2013 ◽  
Vol 32 (4) ◽  
pp. S18-S19 ◽  
Author(s):  
L. Bjurström ◽  
K.H. Andersen ◽  
J. Kjærgaard ◽  
M.P. Iversen ◽  
S. Boesgaard ◽  
...  

2015 ◽  
Vol 62 ◽  
pp. S537-S538
Author(s):  
A. Wald ◽  
L. Deterding ◽  
M. Maier ◽  
U.G. Liebert ◽  
T. Berg ◽  
...  

CHEST Journal ◽  
2021 ◽  
Author(s):  
Oded Breuer ◽  
David Shoseyov ◽  
Shifra Koretz ◽  
Nadia Alyan ◽  
Joel Reiter ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document